Randomized-controlled study of isophane and aspart insulin versus glargine and aspart insulin to treat prednisolone-induced hyperglycaemia in hospitalized patients

被引：0
|
作者：
Radhakutty, Anjana [1 ,2 ,3 ]
Stranks, Jessica L. [1 ]
Mangelsdorf, Brenda L. [1 ]
Drake, Sophie M. [1 ]
Roberts, Gregory W. [3 ,4 ]
Zimmermann, Anthony [2 ]
Stranks, Stephen N. [1 ]
Thompson, Campbell H. [3 ,5 ]
Burt, Morton G. [1 ,3 ]
机构：
[1] Repatriat Gen Hosp, Southern Adelaide Diabet & Endocrine Serv, Adelaide, SA, Australia
[2] Lyell McEwin Hosp, Endocrinol, Adelaide, SA, Australia
[3] Flinders Univ S Australia, Sch Med, Adelaide, SA, Australia
[4] Flinders Med Ctr, Dept Pharm, Adelaide, SA, Australia
[5] Univ Adelaide, Discipline Med, Adelaide, SA, Australia
来源：
CLINICAL ENDOCRINOLOGY | 2017年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
174
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [11] COST-EFFECTIVENESS ANALYSIS OF INSULIN DEGLUDEC/INSULIN ASPART VERSUS INSULIN GLARGINE IN PATIENTS WITH TYPE 2 DIABETES IN CHINA
    Xu, J.
    Lan, K.
    Wang, J.
    VALUE IN HEALTH, 2020, 23 : S111 - S111
  • [12] BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp study
    Heise, Tim
    Meiffren, Gregory
    Alluis, Bertrand
    Seroussi, Cyril
    Ranson, Aymeric
    Arrubla, Jorge
    Correia, Jose
    Gaudier, Martin
    Soula, Olivier
    Soula, Remi
    DeVries, J. Hans
    Klein, Oliver
    Bode, Bruce
    DIABETES OBESITY & METABOLISM, 2019, 21 (04): : 1066 - 1070
  • [13] Insulin Therapy for treating Patients with prednisolone-Induced Hyperglycemia Hospital Records from a randomized, controlled Study
    Jecht, M.
    DIABETOLOGE, 2017, 13 (04): : 268 - 269
  • [14] Once daily initiation with biphasic insulin aspart 30 (BIAsp 30) versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs - a randomized controlled trial
    Franek, E.
    Kalra, S.
    Pesic, M.
    Smahelova, A.
    Thomsen, H.
    Strojek, K.
    DIABETOLOGIA, 2009, 52 : S93 - S93
  • [15] Indirect comparison of efficacy and safety of insulin glargine/lixisenatide and insulin degludec/insulin aspart in type 2 diabetes patients not controlled on basal insulin
    Jammah, Anwar Ali
    PRIMARY CARE DIABETES, 2021, 15 (01) : 132 - 137
  • [16] Comparative efficiency and safety of insulin degludec/aspart with insulin glargine in type 2 diabetes: a meta-analysis of randomized controlled trials
    Long, Tao
    Lin, Jin-ting
    Lin, Min-hua
    Wu, Qian-long
    Lai, Jian-mei
    Li, Sheng-zhen
    Zhou, Zi-chao
    Zeng, Ji-yuan
    Huang, Jia-shuan
    Zeng, Chun-ping
    Lai, Yao-ming
    ENDOCRINE JOURNAL, 2022, 69 (08) : 959 - 969
  • [17] Efficacy and Safety of Once-Daily Insulin Degludec/Insulin Aspart versus Insulin Glargine (U100) for 52 Weeks in Insulin-Naive Patients with Type 2 Diabetes: A Randomized Controlled Trial
    Kumar, Ajay
    Franek, Edward
    Wise, Jonathan
    Niemeyer, Marcus
    Mersebach, Henriette
    Simo, Rafael
    PLOS ONE, 2016, 11 (10):
  • [18] SAFETY AND EFFICACY OF INSULIN GLARGINE/LIXISENATIDE AND INSULIN DEGLUDEC/INSULIN ASPART IN TYPE 2 DIABETES PATIENTS NOT CONTROLLED ON BASAL INSULIN: A NETWORK META-ANALYSIS
    Jammah, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A185 - A186
  • [19] Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: A 26-week, randomised, treat-to-target trial
    Kaneko, Shizuka
    Chow, Francis
    Choi, Dong Seop
    Taneda, Shinji
    Hirao, Koichi
    Park, Yongsoo
    Andersen, Thomas Hasseriis
    Gall, Mari-Anne
    Christiansen, Jens Sandahl
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 107 (01) : 139 - 147
  • [20] Efficacy and safety of once-daily insulin degludec/insulin aspart compared with once-daily insulin glargine in participants with Type 2 diabetes: a randomized, treat-to-target study
    Kumar, S.
    Jang, H. C.
    Demirag, N. G.
    Skjoth, T. V.
    Endahl, L.
    Bode, B.
    DIABETIC MEDICINE, 2017, 34 (02) : 180 - 188
12345